{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T03:33:09Z","timestamp":1768707189957,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,12,25]],"date-time":"2009-12-25T00:00:00Z","timestamp":1261699200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s00280-009-1220-5","type":"journal-article","created":{"date-parts":[[2009,12,24]],"date-time":"2009-12-24T11:11:40Z","timestamp":1261653100000},"page":"755-764","source":"Crossref","is-referenced-by-count":41,"title":["Inhibition of experimental colorectal cancer and reduction in renal and gastrointestinal toxicities by copper\u2013indomethacin in rats"],"prefix":"10.1007","volume":"66","author":[{"given":"Antonio M.","family":"Bonin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime A.","family":"Y\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chie","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao Wei","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn T.","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor W.","family":"Hambley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Lay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal M.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,25]]},"reference":[{"issue":"6","key":"1220_CR1","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2165\/00003495-200262060-00006","volume":"62","author":"K Jolly","year":"2002","unstructured":"Jolly K, Cheng KK, Langman MJ (2002) NSAIDs and gastrointestinal cancer prevention. Drugs 62(6):945\u2013956","journal-title":"Drugs"},{"issue":"5","key":"1220_CR2","first-page":"355","volume":"5","author":"MJ Wargovich","year":"1996","unstructured":"Wargovich MJ, Chen CD, Jimenez A, Steele VE, Velasco M, Stephens LC et al (1996) Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol Biomarkers Prev 5(5):355\u2013360","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1220_CR3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000413416","volume":"55","author":"CL Pirani","year":"1987","unstructured":"Pirani CL, Valeri A, D\u2019Agati V, Appel GB (1987) Renal toxicity of nonsteroidal anti-inflammatory drugs. Contrib Nephrol 55:159\u2013175","journal-title":"Contrib Nephrol"},{"issue":"3","key":"1220_CR4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/sarh.2000.16643","volume":"30","author":"M Rich","year":"2000","unstructured":"Rich M, Scheiman JM (2000) Nonsteroidal anti-inflammatory drug gastropathy at the new millennium: mechanisms and prevention. Semin Arthritis Rheum 30(3):167\u2013179","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"1220_CR5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1021\/tx049806t","volume":"18","author":"S Ramadan","year":"2005","unstructured":"Ramadan S, Bonin AM, Kennedy BJ, Hambley TW, Lay PA (2005) Nuclear magnetic resonance analysis of indomethacin-induced gastric ulcers. Chem Res Toxicol 18(2):123\u2013128","journal-title":"Chem Res Toxicol"},{"issue":"11","key":"1220_CR6","first-page":"1151","volume":"9","author":"JL Wallace","year":"2008","unstructured":"Wallace JL, Vong L (2008) NSAID-induced gastrointestinal damage and the design of GI-sparing NSAIDs. Curr Opin Investig Drugs 9(11):1151\u20131156","journal-title":"Curr Opin Investig Drugs"},{"issue":"1","key":"1220_CR7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/138955709787001695","volume":"9","author":"PK Halen","year":"2009","unstructured":"Halen PK, Murumkar PR, Giridhar R, Yadav MR (2009) Prodrug designing of NSAIDs. Mini Rev Med Chem 9(1):124\u2013139","journal-title":"Mini Rev Med Chem"},{"issue":"6 Suppl 25","key":"1220_CR8","first-page":"S37","volume":"19","author":"GB Appel","year":"2001","unstructured":"Appel GB (2001) COX-2 inhibitors and the kidney. Clin Exp Rheumatol 19(6 Suppl 25):S37\u201340","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"1220_CR9","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0006-2952(02)00842-0","volume":"63","author":"D Mukherjee","year":"2002","unstructured":"Mukherjee D (2002) Selective cyclooxygenase-2 (COX-2) inhibitors and potential risk of cardiovascular events. Biochem Pharmacol 63(5):817\u2013821","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"1220_CR10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2165\/00003088-200847110-00002","volume":"47","author":"JK Takemoto","year":"2008","unstructured":"Takemoto JK, Reynolds JK, Remsberg CM, Vega-Villa KR, Davies NM (2008) Clinical pharmacokinetic and pharmacodynamic profile of etoricoxib. Clin Pharmacokin 47(11):703\u2013720","journal-title":"Clin Pharmacokin"},{"issue":"1","key":"1220_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00210-006-0044-7","volume":"373","author":"I Tegeder","year":"2006","unstructured":"Tegeder I, Geisslinger G (2006) Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences? Naunyn Schmiedebergs Arch Pharmacol 373(1):1\u201317","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1\u20132","key":"1220_CR12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0010-8545(02)00086-3","volume":"232","author":"JE Weder","year":"2002","unstructured":"Weder JE, Dillon CT, Hambley TW, Kennedy BJ, Lay PA, Biffin JR et al (2002) Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized. Coord Chem Rev 232(1\u20132):95\u2013126","journal-title":"Coord Chem Rev"},{"key":"1220_CR13","first-page":"253","volume":"41","author":"CT Dillon","year":"2004","unstructured":"Dillon CT, Hambley TW, Kennedy BJ, Lay PA, Weder JE, Zhou Q (2004) Copper and zinc complexes as anti-inflammatory drugs. Met Ions Biol Syst 41:253\u2013277","journal-title":"Met Ions Biol Syst"},{"key":"1220_CR14","unstructured":"Medical Therapies Ltd, Sydney (2008) http:\/\/www.asx.com.au\/asxpdf\/20080215\/pdf\/317g8lzm161jgt.pdf"},{"issue":"1","key":"1220_CR15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1021\/tx020078o","volume":"6","author":"CT Dillon","year":"2003","unstructured":"Dillon CT, Hambley TW, Kennedy BJ, Lay PA, Zhou Q, Davies NM, Biffin JR, Regtop HL (2003) Gastrointestinal toxicity, antiinflammatory activity, and superoxide dismutase activity of copper and zinc complexes of the antiinflammatory drug indomethacin. Chem Res Toxicol 6(1):28\u201337","journal-title":"Chem Res Toxicol"},{"issue":"8","key":"1220_CR16","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1021\/ic981100x","volume":"38","author":"JE Weder","year":"1999","unstructured":"Weder JE, Hambley TW, Kennedy BJ, Lay PA, MacLachlan D, Bramley R, Delfs CD, Murray KS, Moubaraki B, Warwick B, Biffin JR, Regtop HL (1999) Anti-inflammatory dinuclear copper(II) complexes with indomethacin. Synthesis, magnetism and EPR spectroscopy; crystal structure of the N,N-dimethylformamide adduct. Inorg Chem 38(8):1736\u20131744","journal-title":"Inorg Chem"},{"issue":"6","key":"1220_CR17","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1046\/j.1365-2036.1997.00247.x","volume":"11","author":"NM Davies","year":"1997","unstructured":"Davies NM, Sharkey KA, Asfaha S, Macnaughton WK, Wallace JL (1997) Aspirin causes rapid up-regulation of cyclo-oxygenase-2 expression in the stomach of rats. Aliment Pharmacol Ther 11(6):1101\u20131108","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"1220_CR18","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1023\/A:1016221923679","volume":"12","author":"NM Davies","year":"1995","unstructured":"Davies NM, Corrigan BW, Jamali F (1995) Sucrose urinary excretion in the rat measured using a simple assay: a model of gastroduodenal permeability. Pharmaceut Res 12(11):1733\u20131736","journal-title":"Pharmaceut Res"},{"issue":"2","key":"1220_CR19","first-page":"15","volume":"14","author":"R Melarange","year":"1994","unstructured":"Melarange R, Gentry C, Blower PR, Toseland CD, Spangler R (1994) Nabumetone, an effective anti-inflammatory agent, lacks gastrointestinal irritancy in the rat when dosed orally for one month: comparison with tiaprofenic acid and etodolac. Eur J Rheumatol Inflam 14(2):15\u201322","journal-title":"Eur J Rheumatol Inflam"},{"issue":"1","key":"1220_CR20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2036.1997.115286000.x","volume":"11","author":"NM Davies","year":"1997","unstructured":"Davies NM, Roseth AG, Appleyard CB, McKnight W, Del Soldato P, Calignano A et al (1997) NO-naproxen vs. naproxen: ulcerogenic, analgesic and anti-inflammatory effects. Aliment Pharmacol Ther 11(1):69\u201379","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"1220_CR21","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1023\/A:1018978308752","volume":"11","author":"NM Davies","year":"1994","unstructured":"Davies NM, Wright MR, Jamali F (1994) Antiinflammatory drug-induced small intestinal permeability: the rat is a suitable model. Pharmaceut Res 11(11):1652\u20131656","journal-title":"Pharmaceut Res"},{"issue":"1","key":"1220_CR22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0016-5085(97)70225-7","volume":"112","author":"BK Reuter","year":"1997","unstructured":"Reuter BK, Davies NM, Wallace JL (1997) Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation. Gastroenterology 112(1):109\u2013117","journal-title":"Gastroenterology"},{"issue":"3","key":"1220_CR23","first-page":"308","volume":"6","author":"JA Yanez","year":"2003","unstructured":"Yanez JA, Teng XW, Roupe KA, Fariss MW, Davies NM (2003) Chemotherapy induced gastrointestinal toxicity in rats: involvement of mitochondrial DNA, gastrointestinal permeability and cyclooxygenase-2. J Pharm Pharm Sci 6(3):308\u2013314","journal-title":"J Pharm Pharm Sci"},{"issue":"2","key":"1220_CR24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/meth.2000.1054","volume":"22","author":"S Ayala-Torres","year":"2000","unstructured":"Ayala-Torres S, Chen Y, Svoboda T, Rosenblatt J, Van Houten B (2000) Analysis of gene-specific DNA damage and repair using quantitative polymerase chain reaction. Methods 22(2):135\u2013147","journal-title":"Methods"},{"key":"1220_CR25","first-page":"159","volume":"197","author":"JH Santos","year":"2002","unstructured":"Santos JH, Mandavilli BS, Van Houten B (2002) Measuring oxidative mtDNA damage and repair using quantitative PCR. Methods Mol Biol 197:159\u2013176","journal-title":"Methods Mol Biol"},{"issue":"5","key":"1220_CR26","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/gut.48.5.660","volume":"48","author":"WA Brown","year":"2001","unstructured":"Brown WA, Skinner SA, Malcontenti-Wilson C, Vogiagis D, O\u2019Brien PE (2001) Non-steroidal anti-inflammatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a DMH rodent model by inducing apoptosis and inhibiting cell proliferation. Gut 48(5):660\u2013666","journal-title":"Gut"},{"issue":"6","key":"1220_CR27","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1006\/phrs.1997.0194","volume":"35","author":"MR Wright","year":"1997","unstructured":"Wright MR, Davies NM, Jamali F (1997) Toxicokinetics of indomethacin-induced intestinal permeability in the rat. Pharmacol Res 35(6):499\u2013504","journal-title":"Pharmacol Res"},{"issue":"5","key":"1220_CR28","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1023\/A:1026668816189","volume":"44","author":"V Bertrand","year":"1999","unstructured":"Bertrand V, Guessous F, Le Roy AL, Viossat B, Fessi H, El Abbouyi A et al (1999) Copper-indomethacinate associated with zwitterionic phospholipids prevents enteropathy in rats: effect on inducible NO synthase. Dig Dis Sci 44(5):991\u2013999","journal-title":"Dig Dis Sci"},{"issue":"1","key":"1220_CR29","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12011-007-8063-x","volume":"122","author":"Y Chang-Ying","year":"2008","unstructured":"Chang-Ying Y, Yi L, Jun-Cheng Z, Dan Z (2008) Inhibitory effect of copper complex of indomethacin on bacteria studied by microcalorimetry. Biol Trace Elem Res 122(1):82\u201388","journal-title":"Biol Trace Elem Res"},{"issue":"3","key":"1220_CR30","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.2042-7158.1987.tb06256.x","volume":"39","author":"T Fujita","year":"1987","unstructured":"Fujita T, Ohtani N, Aihara M, Nishioka K, Fujimoto Y (1987) Comparison of the effects of Fe2+ and Cu2+ on prostaglandin synthesis in rabbit kidney medulla slices. J Pharm Pharmacol 39(3):230\u2013233","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"1220_CR31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/cmdc.200700217","volume":"3","author":"S Nagano","year":"2008","unstructured":"Nagano S, Bush AI (2008) Sensitive, selective, and irreversible inhibition of cyclooxygenase-2 activity by copper. Chem Med Chem 3(2):223\u2013225","journal-title":"Chem Med Chem"},{"issue":"8","key":"1220_CR32","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/jps.2600830808","volume":"83","author":"SY Lee","year":"1994","unstructured":"Lee SY, Belmonte AA (1994) Effect of sodium deoxycholate on the dissolution and absorption of copper-indomethacin and zinc-indomethacin. J Pharm Sci 83(8):1107\u20131109","journal-title":"J Pharm Sci"},{"issue":"17","key":"1220_CR33","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1021\/ic991477i","volume":"39","author":"Q Zhou","year":"2000","unstructured":"Zhou Q, Hambley TW, Kennedy BJ, Lay PA, Turner P, Warwick B, Biffin JR, Regtop HL (2000) Syntheses and characterization of anti-inflammatory dinuclear and mononuclear zinc indomethacin complexes. Crystal structures of [Zn2(Indomethacin)4(L)2] (L\u00a0=\u00a0N,N-dimethylacetamide, pyridine, 1-methyl-2-pyrrolidinone) and [Zn(Indomethacin)2(L1)2] (L1\u00a0=\u00a0ethanol, methanol). Inorg Chem 39(17):3742\u20133748","journal-title":"Inorg Chem"},{"issue":"6","key":"1220_CR34","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1021\/ic0007815","volume":"40","author":"JE Weder","year":"2001","unstructured":"Weder JE, Hambley TW, Kennedy BJ, Lay PA, Foran GJ, Rich AM (2001) Determination of the structures of antiinflammatory copper(II) dimers of indomethacin by multiple-scattering analyses of X-ray absorption fine structure data. Inorg Chem 40(6):1295\u20131302","journal-title":"Inorg Chem"},{"issue":"1\u20132","key":"1220_CR35","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0020-1693(01)00570-9","volume":"324","author":"YR Morgan","year":"2001","unstructured":"Morgan YR, Turner P, Kennedy BJ, Hambley TW, Lay PA, Biffin JR, Regtop HL, Warwick B (2001) Preparation and characterization of dinuclear copper-indomethacin anti-inflammatory drugs. Inorg Chim Acta 324(1\u20132):150\u2013161","journal-title":"Inorg Chim Acta"},{"issue":"25","key":"1220_CR36","doi-asserted-by":"crossref","first-page":"8557","DOI":"10.1021\/ic034049s","volume":"42","author":"Q Zhou","year":"2003","unstructured":"Zhou Q, Hambley TW, Kennedy BJ, Lay PA (2003) XAFS studies of anti-inflammatory dinuclear and mononuclear Zn(II) complexes of indomethacin. Inorg Chem 42(25):8557\u20138566","journal-title":"Inorg Chem"},{"key":"1220_CR37","unstructured":"Lay P, Hambley T, Weder J, Davies N, Regtop HL, Biffin JR, Kennedy B (2005) A pharmaceutical composition containing a complex comprising a metal ion and a carboxylate ligand having antiinflammatory activity. PCT Int WO 2005094809"},{"key":"1220_CR38","unstructured":"Lay P, Hambley T, Kennedy B, Morgan Y, Kaur R, Davies N (2006) Preparation of transition metal acemetacin complexes with antiinflammatory activity. PCT Int. Appl WO 2006099677"},{"key":"1220_CR39","unstructured":"Lay P, Hambley T, Kennedy B, Morgan Y (2006) Preparation of copper indomethacin complexes having antiinflammatory activity. PCT Int WO 2006099684"},{"key":"1220_CR40","unstructured":"Lay P, Hambley T (2007) Anti-inflammatory metal complexes useful in treatment of inflammation, cancer, diabetes, cardiovascular and other conditions. PCT Int Appl WO 2007109844 A1"},{"key":"1220_CR41","unstructured":"Lay P, Hambley T (2007) Anti-inflammatory metal complexes useful in treatment of inflammation, cancer, diabetes, cardiovascular and other conditions. PCT Int Appl WO 2007109843"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-009-1220-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-009-1220-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-009-1220-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T10:07:04Z","timestamp":1559038024000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-009-1220-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,25]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["1220"],"URL":"https:\/\/doi.org\/10.1007\/s00280-009-1220-5","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,25]]}}}